CONMED Operating Expenses 2010-2024 | CNMD

CONMED operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
CONMED Annual Operating Expenses
(Millions of US $)
2023 $1,124
2022 $975
2021 $901
2020 $816
2019 $876
2018 $788
2017 $749
2016 $726
2015 $668
2014 $687
2013 $706
2012 $702
2011 $717
2010 $657
2009 $666
CONMED Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $251
2024-06-30 $285
2024-03-31 $277
2023-12-31 $277
2023-09-30 $274
2023-06-30 $290
2023-03-31 $283
2022-12-31 $252
2022-09-30 $251
2022-06-30 $253
2022-03-31 $220
2021-12-31 $237
2021-09-30 $222
2021-06-30 $229
2021-03-31 $213
2020-12-31 $228
2020-09-30 $208
2020-06-30 $179
2020-03-31 $201
2019-12-31 $237
2019-09-30 $213
2019-06-30 $220
2019-03-31 $207
2018-12-31 $217
2018-09-30 $191
2018-06-30 $196
2018-03-31 $185
2017-12-31 $199
2017-09-30 $177
2017-06-30 $184
2017-03-31 $189
2016-12-31 $191
2016-09-30 $171
2016-06-30 $186
2016-03-31 $178
2015-12-31 $178
2015-09-30 $154
2015-06-30 $169
2015-03-31 $167
2014-12-31 $178
2014-09-30 $173
2014-06-30 $172
2014-03-31 $165
2013-12-31 $187
2013-09-30 $170
2013-06-30 $177
2013-03-31 $171
2012-12-31 $184
2012-09-30 $168
2012-06-30 $173
2012-03-31 $177
2011-12-31 $227
2011-09-30 $157
2011-06-30 $167
2011-03-31 $166
2010-12-31 $171
2010-09-30 $157
2010-06-30 $166
2010-03-31 $163
2009-12-31 $180
2009-09-30 $170
2009-06-30 $160
2009-03-31 $157
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.268B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.492B 21.23
Becton Dickinson (BDX) United States $66.954B 17.60
Cardinal Health (CAH) United States $29.177B 15.82
West Pharmaceutical Services (WST) United States $23.472B 47.94
Cooper (COO) United States $20.662B 29.41
Labcorp (LH) United States $20.273B 16.81
Align Technology (ALGN) United States $16.462B 31.50
Henry Schein (HSIC) United States $8.478B 16.15
Merit Medical Systems (MMSI) United States $5.988B 30.58
DENTSPLY SIRONA (XRAY) United States $3.620B 9.65
Patterson (PDCO) United States $1.833B 9.67
STAAR Surgical (STAA) United States $1.458B 53.80
Lifevantage (LFVN) United States $0.171B 22.77
Pro-Dex (PDEX) United States $0.139B 27.71